1. 2753 Feasibility of implementing routine genomic and proteomic profiling for advanced GYN malignancies. (September 2015) Authors: Williams, C.; Rojas, L.; Starks, D.; Williams, K.; Solomon, B.; Klein, J.; Dey, N.; De, P.; Leyland-Jones, B. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S548 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 3009 Activity of rociletinib in EGFR mutant NSCLC patients with a history of CNS involvement. (September 2015) Authors: Varga, A.; Camidge, D.R.; Sequist, L.V.; Wakelee, H.; Ou, S.H.; Goldman, J.W.; Papadimitrakopoulou, V.; Gadgeel, S.; Mekhail, T.; Oxnard, G.R.; Socinski, M.; Solomon, B.; Yu, H.; Matheny, S.; Despain, D.; Soria, J.C. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S598 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 3088 Efficacy of rociletinib (co-1686) in EGFR-mutant non-small cell lung cancer (NSCLC) patients (pts) assessed with a plasma EGFR test. (September 2015) Authors: Gadgeel, S.; Soria, J.C.; Goldman, J.W.; Wakelee, H.; Camidge, D.R.; Yu, H.; Varga, A.; Solomon, B.; Oxnard, G.R.; Ou, S.H.; Papadimitrakopoulou, V.; Liu, S.V.; Reckamp, K.; Spira, A.; Piotrowska, Z.; Despain, D.; Karlovich, C.; Yurasov, S.; Sequist, L.V. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S628 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 3104 Rociletinib treatment and outcomes in non-small cell lung cancer (NSCLC) patients with negative central testing for T790M. (September 2015) Authors: Solomon, B.; Wakelee, H.; Sequist, L.V.; Gadgeel, S.; Soria, J.C.; Goldman, J.W.; Yu, H.; Camidge, D.R.; Papadimitrakopoulou, V.; Matheny, S.; Despain, D.; Besse, B. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S636 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 3105 Dose optimization of rociletinib for EGFR mutated NSCLC: Benefit/risk analysis from the TIGER-X trial. (September 2015) Authors: Soria, J.C.; Goldman, J.W.; Wakelee, H.; Gadgeel, S.; Camidge, D.R.; Solomon, B.; Yu, H.; Oxnard, G.R.; Ou, S.H.; Papadimitrakopoulou, V.; Perol, M.; Reckamp, K.; Varga, A.; Dziadziuszko, R.; Chouaid, C.; Cortot, A.; Do, P.; Moro-Sibilot, D.; Poudenx, M.; Sequist, L.V. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S637 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Chloropyramine increases NSCLC sensitivity to cisplatin in a SASH1 dependent manner. (January 2019) Authors: Burgess, J.; Bolderson, E.; Adams, M.; Zhang, S.; Fox, S.; Wright, G.; Young, R.; Solomon, B.; Gray, S.; Richard, D.; O'Byrne, K. Journal: Lung cancer Issue: Volume 127(2019)Supplement 1 Page Start: S1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Dynamic thromboembolism risk modelling in patients with non-small cell lung cancer: a prospective cohort study. Issue 164 (April 2018) Authors: Alexander, M.; Ball, D.; Solomon, B.; MacManusb, M.; Manser, R.; Riedel, B.; Westerman, D.; Evans, S.M.; Wolfe, R.; Burbury, K. Journal: Thrombosis research Issue: Issue 164(2018)Supplement 1 Page Start: S189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. OC-05 - D-Dimer, fibrinogen and TEG-MA predict thromboembolism in non-small cell lung cancer – interim results from a prospective cohort study. Issue 140 (April 2016) Authors: Alexander, M.; Wolfe, R.; Ball, D.; Manser, R.; McManus, M.; Riedel, B.; Solomon, B.; Westerman, D.; Burbury, K. Journal: Thrombosis research Issue: Issue 140(2016)Supplement 1 Page Start: S170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. OC-0537: p16 and high risk-HPV in node positive cutaneous squamous cell carcinoma of the head and neck. (April 2016) Authors: McDowell, L.; Young, R.; Johnston, M.; Tan, T.; Liu, C.; Bressel, M.; Estall, V.; Solomon, B.; Corry, J. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. OC-15: Targeted thromboprophylaxis in ambulatory patients receiving anticancer therapies for lung or gastrointestinal cancers (TARGET-TP); a randomized trial. Issue 213 (May 2022) Authors: Alexander, M.; Harris, S.J.; Underhill, C.; Torres, J.; Sharma, S.; Lee, N.; Wong, H.; Eek, R.; Michael, M.; Tie, J.; Rogers, J.; Heriot, A.; Ball, D.; MacManus, M.; Wolfe, R.; Solomon, B.; Burbury, K. Journal: Thrombosis research Issue: Issue 213(2022)Supplement 2 Page Start: S9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗